Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hepatitis - B 2010 NIAID 1RC1AI085952-01 Influence of Naive Lymphocyte Repertoire Size on Vaccination Efficancy JENKINS, MARC UNIVERSITY OF MINNESOTA TWIN CITIES MN $458,770
Hepatitis - B 2010 NCI 5R21CA135192-02 Role of Polo-like kinase (Plk-1) in Hepatitis B Virus-mediated Hepatocellular Car ANDRISANI, OURANIA PURDUE UNIVERSITY WEST LAFAYETTE IN $167,750
Hepatitis - B 2010 NIAID 5R21AI083106-02 Virologic and Serologic Outcomes of Persons with HIV and HBV co-infection on Mono ABERG, JUDITH NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $169,000
Hepatitis - B 2010 NCI 5R01CA055678-19 DNA Adduct-Induced Mutagenesis STONE, MICHAEL VANDERBILT UNIVERSITY TN $251,664
Hepatitis - B 2010 NIAID 5R21AI077532-02 10-Theory and Experiment for Genome Packaging in HBV Nucleocapsids WU, JIANZHONG UNIVERSITY OF CALIFORNIA RIVERSIDE CA $237,747
Hepatitis - B 2010 NIAAA 5R21AA017458-02 A Microfluidic-platform Mini-Liver System for Human Liver Biology Studies BOUCHARD, MICHAEL DREXEL UNIVERSITY PA $190,482
Hepatitis - B 2010 NIAID 5R01AI043453-13 Mechanisms of Hepadnavirus Assembly and Replication HU, JIANMING PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $386,152
Hepatitis - B 2010 NIAID 1R43AI089149-01 Stability and functionality of the Immunoject single-dose, auto-reconstitution de QUINN, BRIAN AKTIV-DRY, LLC CO $66,109
Hepatitis - B 2010 OD 1R43AI089149-01 Stability and functionality of the Immunoject single-dose, auto-reconstitution de QUINN, BRIAN AKTIV-DRY, LLC CO $133,891
Hepatitis - B 2010 NIAAA 5R21AA018372-02 Ethanol and HBV Infection on HCC Development in A Novel Humanized Mouse Model SU, LISHAN UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $204,668
Hepatitis - B 2010 NCI 5RC1CA146279-02 Hepatitis B Virus PreS2 Mutant as Risk Factor for Hepatocellular Carcinoma HUANG, ERIC NORTHERN CALIFORNIA INSTITUTE RES & EDUC CA $231,839
Hepatitis - B 2010 FIC 3K01TW007408-04S1 Blood-borne infection screening in an Afghan antenatal population TODD, CATHERINE COLUMBIA UNIVERSITY HEALTH SCIENCES NY $103,661
Hepatitis - B 2010 NIAID 5F31AI081451-02 Metabolic control of hepatitis B virus (HBV) biosynthesis: role of FXR and SHP REESE, VANESSA UNIVERSITY OF ILLINOIS AT CHICAGO IL $41,380
Hepatitis - B 2010 NIAID 1U19AI089987-01 5538 Systems Biology Analysis of the Response to 2 HBV vaccines: Heplisav and Engerix COFFMAN, ROBERT DYNAVAX TECHNOLOGIES CORPORATION CA $568,825
Hepatitis - B 2010 NIAID 1U19AI089987-01 5545 Protein Core ZURAWSKI, GERARD BAYLOR RESEARCH INSTITUTE TX $326,866
Hepatitis - B 2010 NIAID 3R01AI071068-04S1 RNAi for the Treatment of Viral Hepatitis KAY, MARK STANFORD UNIVERSITY CA $183,150
Hepatitis - B 2010 NIEHS 3R21ES015954-02S3 Activating liver carcinogens in yeast by expressing CYP450 polymorphisms FASULLO, MICHAEL ORDWAY RESEARCH INSTITUTE, INC. NY $18,392


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer